GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » Accumulated other comprehensive income (loss)

AEterna Zentaris (TSX:AEZS) Accumulated other comprehensive income (loss) : C$-1.58 Mil (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is AEterna Zentaris Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. AEterna Zentaris's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was C$-1.58 Mil.

AEterna Zentaris's quarterly Accumulated other comprehensive income (loss) increased from Jun. 2023 (C$-1.51 Mil) to Sep. 2023 (C$-1.10 Mil) but then declined from Sep. 2023 (C$-1.10 Mil) to Dec. 2023 (C$-1.58 Mil).

AEterna Zentaris's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (C$-0.87 Mil) to Dec. 2022 (C$-1.31 Mil) and declined from Dec. 2022 (C$-1.31 Mil) to Dec. 2023 (C$-1.58 Mil).


AEterna Zentaris Accumulated other comprehensive income (loss) Historical Data

The historical data trend for AEterna Zentaris's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AEterna Zentaris Accumulated other comprehensive income (loss) Chart

AEterna Zentaris Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 -1.34 -0.87 -1.31 -1.58

AEterna Zentaris Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.31 -1.55 -1.51 -1.10 -1.58

AEterna Zentaris Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


AEterna Zentaris Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of AEterna Zentaris's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


AEterna Zentaris (TSX:AEZS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AEterna Zentaris Inc (TSX:AEZS) » Definitions » Accumulated other comprehensive income (loss)
Traded in Other Exchanges
Address
222 Bay Street, Suite 3000, PO Box 53, c/o Norton Rose Fulbright Canada, LLP, Toronto, ON, CAN, M5K 1E7
AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland.